Live Streaming
Program Highlight
Company Profile
President: Prepare Covid-19 Vaccination Plan In Two Weeks
Written by Nur Yasmin
-
font size
decrease font size
increase font size
President Joko Widodo (right) observes the COVID-19 vaccine production facility at Bio Farma, Bandung, West Java, accompanied by the Head of the Pharmaceutical Production Division, Hikmat Alitamsar.
Biofarma
President Joko Widodo asked related government officials to prepare a detailed plan for the implementation of the COVID-19 vaccination within two weeks.
"So when the vaccine is available, we are ready to implement it directly," he said in a virtual limited meeting regarding the Report of the Committee on Handling COVID-19 and National Economic Recovery, at the State Palace, Jakarta, on Monday.
"The vaccination plan have to be planned in detail as early as possible," the President said.
He said that vaccination planning must include the timing, location, implementing agency, and vaccination targets.
Indonesia has two choices of sources for the COVID-19 vaccine, the first is the Merah Putih vaccine, which is being developed by the Ministry of Research and Technology, the National Research and Innovation Agency, and the Eijkman Institute for Molecular Biology.
The Ministry of Research and Technology hopes that mass production of the Merah Putih vaccine can begin in late 2021.
The second option is the vaccine produced in collaboration with pharmaceutical companies from other countries, namely vaccines produced by the Chinese pharmaceutical company Sinovac, vaccines in collaboration with Sinopharm and Group 42 from the United Arab Emirates, and a vaccine from a collaboration between Genexine from South Korea and PT Kalbe Farma. (Antaranews)
